It was reported that patient experienced acute thrombosis.After placing a synergy drug-eluting stent, an acute thrombosis occurred.No further complications were reported.It was further reported that the 100% stenosed, 3.5x38mm, de novo, type c, thrombotic target lesion was located in the mid right coronary artery (rca).After aspirating thrombus of right posterior descending artery and mid rca, intravenous ultrasound (ivus) was performed and the lesion was pre-expanded with 3.5x10m wolverine cutting balloon.A 4.00x38mm synergy ii drug-eluting stent was placed at 14 atmospheres.After ivus confirmation, the procedure was completed.On the same day, a stent thrombus was found.As a treatment, an aspiration of thrombus was perfomed and additional dilatation was performed with a 4mm non-compliant balloon.No patient complications were reported and the patient's status was good.As per physician's comment, thrombocytosis was observed, suggesting that thrombocythemia may have caused thrombus in th stent.It was considered that it was more likely due to patient factors than thrombosis due to stent.
|